scholarly article | Q13442814 |
P356 | DOI | 10.1111/ALL.12327 |
P698 | PubMed publication ID | 24354793 |
P2093 | author name string | M Bauer | |
M F Bachmann | |||
G Senti | |||
T M Kündig | |||
P Saudan | |||
R R Beerli | |||
F Zabel | |||
C Uermösi | |||
V Manolova | |||
P2860 | cites work | Immunological mechanisms of allergen-specific immunotherapy | Q28265326 |
Isolation of human monoclonal antibodies by mammalian cell display | Q33371477 | ||
FcepsilonRI signaling observed from the inside of the mast cell membrane | Q34148294 | ||
Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper | Q34754637 | ||
Mechanisms of immunotherapy: IgG revisited | Q35828396 | ||
Mast cells as "tunable" effector and immunoregulatory cells: recent advances. | Q36072458 | ||
Observing FcepsilonRI signaling from the inside of the mast cell membrane | Q36327555 | ||
IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy | Q36545702 | ||
Cytokine production by mast cells and basophils | Q36970535 | ||
IgE in allergy and asthma today | Q37095248 | ||
Intergenerational 20 year trends in the prevalence of asthma and hay fever in adults: the Midspan family study surveys of parents and offspring | Q37344166 | ||
Vaccination with genetically engineered allergens prevents progression of allergic disease. | Q37569798 | ||
Ubiquitination and endocytosis of the high affinity receptor for IgE. | Q37773596 | ||
Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. | Q40342009 | ||
Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. | Q41166947 | ||
Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy | Q41895016 | ||
The epidemic of allergy and asthma | Q43547661 | ||
IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy | Q44429951 | ||
Inhibition of allergen-specific IgE reactivity by a human Ig Fcgamma-Fcepsilon bifunctional fusion protein. | Q45956509 | ||
A chimeric human-cat fusion protein blocks cat-induced allergy | Q46483879 | ||
Development of an in vitro system for the study of allergens and allergen-specific immunoglobulin E and immunoglobulin G: Fcepsilon receptor I supercross-linking is a possible new mechanism of immunoglobulin G-dependent enhancement of type I allergi | Q46559696 | ||
The blocking activity of birch pollen-specific immunotherapy-induced IgG4 is not qualitatively superior to that of other IgG subclasses | Q47379187 | ||
Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom | Q52455489 | ||
The same tyrosine-based inhibition motif, in the intra-cytoplasmic domain of FcγRIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation | Q56966801 | ||
Immunotherapy with cat- and dog-dander extracts | Q57319721 | ||
P433 | issue | 3 | |
P921 | main subject | mast cell | Q191989 |
P304 | page(s) | 338-347 | |
P577 | publication date | 2013-12-19 | |
P1433 | published in | Allergy | Q2699825 |
P1476 | title | IgG-mediated down-regulation of IgE bound to mast cells: a potential novel mechanism of allergen-specific desensitization | |
P478 | volume | 69 |
Q90353156 | Anti-IgE therapy for IgE-mediated allergic diseases: from neutralizing IgE antibodies to eliminating IgE+ B cells |
Q42079107 | Chronic cat allergen exposure induces a TH2 cell-dependent IgG4 response related to low sensitization |
Q36209516 | Combination of two epitope identification techniques enables the rational design of soy allergen Gly m 4 mutants |
Q57475786 | Early IL-10 producing B-cells and coinciding Th/Tr17 shifts during three year grass-pollen AIT |
Q51533953 | Efficacy of a therapeutic treatment using gas-filled microbubble-associated phospholipase A2 in a mouse model of honeybee venom allergy |
Q38973411 | IgE-associated allergic disorders: recent advances in etiology, diagnosis, and treatment |
Q34445626 | Immunization with Hypoallergens of shrimp allergen tropomyosin inhibits shrimp tropomyosin specific IgE reactivity |
Q46222311 | Immunotherapy of Food Allergy: a Comprehensive Review |
Q37343952 | Immunotherapy using algal-produced Ara h 1 core domain suppresses peanut allergy in mice |
Q47609875 | Low-Dose Allergen-Specific Immunotherapy Induces Tolerance in a Murine Model of Shrimp Allergy |
Q26824984 | Mast cell activation: a complex interplay of positive and negative signaling pathways |
Q99419174 | Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts |
Q38857421 | Novel strategies for the treatment of grass pollen-induced allergic rhinitis |
Q41135569 | Oral application of lactic acid bacteria following treatment with antibiotics inhibits allergic airway inflammation |
Q51015029 | Primary Manifestation of Inflammatory Bowel Disease Following Subcutaneous Autovaccination |
Q41031692 | Prophylactic immunization of mice with phospholipase A2-loaded gas-filled microbubbles is protective against Th2-mediated honeybee venom allergy |
Q38895325 | Pros and Cons of Clinical Basophil Testing (BAT). |
Q49206571 | Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment |
Q89509988 | The Toxicological Intersection between Allergen and Toxin: A Structural Comparison of the Cat Dander Allergenic Protein Fel d1 and the Slow Loris Brachial Gland Secretion Protein |
Q38259275 | The contribution of biotechnology toward progress in diagnosis, management, and treatment of allergic diseases. |
Q48093883 | The role of basophils as innate immune regulatory cells in allergy and immunotherapy |
Q55277398 | Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement. |
Search more.